Childrens Place, Inc.: Form 10-Q for the period ended Oct 31, 2015
Filed with the SEC on Dec 8, 2015 and accepted by EDGAR at Dec 8, 2015, 16:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-08-02 to 2015-10-31 | $455.9m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2015-02-01 to 2015-10-31 | $1.23bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2015-08-02 to 2015-10-31 | $275.4m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2015-02-01 to 2015-10-31 | $779.6m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2015-08-02 to 2015-10-31 | $180.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2015-02-01 to 2015-10-31 | $447.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2015-08-02 to 2015-10-31 | $105.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2015-02-01 to 2015-10-31 | $338.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2015-08-02 to 2015-10-31 | $57.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2015-02-01 to 2015-10-31 | $60.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-08-02 to 2015-10-31 | $472.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2015-02-01 to 2015-10-31 | $1.4m | us-gaap:InterestExpense |
| Income tax | 3 months2015-08-02 to 2015-10-31 | $18.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2015-02-01 to 2015-10-31 | $19.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-08-02 to 2015-10-31 | $38.5m | us-gaap:ProfitLoss |
| Net income | 9 months2015-02-01 to 2015-10-31 | $40.4m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2015-08-02 to 2015-10-31 | $1.88 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2015-02-01 to 2015-10-31 | $1.94 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-08-02 to 2015-10-31 | $1.90 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2015-02-01 to 2015-10-31 | $1.96 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-08-02 to 2015-10-31 | 20,517,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2015-02-01 to 2015-10-31 | 20,878,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2015-02-01 to 2015-10-31 | $85.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2015-08-02 to 2015-10-31 | $13.8m | us-gaap:PaymentsToAcquireProductiveAssets |
| Capital expenditure | 9 months2015-02-01 to 2015-10-31 | $34.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2015-02-01 to 2015-10-31 | −$9.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2015-02-01 to 2015-10-31 | $82.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-10-31 | $183.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-10-31 | $634.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-10-31 | $977.4m | us-gaap:Assets |
| Current liabilities | At period end2015-10-31 | $333.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-10-31 | $427.8m | us-gaap:Liabilities |
| Short-term borrowings | At period end2015-10-31 | $34.4m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2015-10-31 | $549.5m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0001628280-15-009306. Last ingested by Listed: Nov 12, 2026, 18:00 ET. Listed shows no prices and gives no investment advice.